CompletedNot Applicable

A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation

United States32 participantsStarted 2022-01-11

Plain-language summary

This single-center clinical trial was conducted to evaluate the efficacy and tolerability of a topical facial treatment when applied by a license esthetician in clinic in a series of 3 sessions with 1 month intervals, in combination with a cleanser, moisturizer, and sunscreen over the course of 12 weeks in healthy women aged 35 to 60 with mild to moderate global facial fine lines, wrinkles, and laxity. Thirty-two (32) healthy female subjects completed the clinical study.

Who can participate

Age range35 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having Fitzpatrick Skin Type I - VI * Having mid to moderate global face fine lines, wrinkles, and laxtiy (tactile) (score of 3 to 6 according to a modified Griffiths scale). Exclusion Criteria: * Breastfeeding, pregnant, or planning to become pregnant during the study. * Currently having or having a history of cold sores (Herpes simplex) on the face.

What they're measuring

Change Investigator Clinical Efficacy Grading versus Baseline

Timeframe: 12 weeks

Lack of significant change in Investigator Tolerability Parameters versus Baseline

Timeframe: 12 weeks

Lack of significant change in Subjective Tolerability versus Baseline

Timeframe: 12 weeks

Trial details

NCT IDNCT06629792

SponsorRevision Skincare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-05-05

View on ClinicalTrials.gov More Fine Lines trials